Phosphate Assessment in Chronic Kidney Disease Patients Study

Recruiting N/A Interventional Study
Chronic Kidney Disease (Stage 3-4) Chronic Kidney Disease Mineral and Bone Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
60 (estimated)
Sponsor
University of Texas Southwestern Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The proposed pilot feeding study aims to explore novel pathways in phosphate metabolism and identify new biomarkers, as well as to develop a compound index for assessing phosphate overload with high validity and reliability. Investigators will address the following specific aims: 1). To explore novel pathways of phosphate metabolism and assess the influence of CKD status on these metabolic pathwa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men or women aged 18 years or older, of any race/ethnicity * Women must either be post-menopausal or have no monthly menstrual cycle * Estimated total daily energy expenditure (TDEE) of 1700 - 2700 calories * eGFR \>15 ml/min/1.73m2 - \< 60 ml/min/1.73m2 for the CKD group (CKD…
Contacts

Alexandra Hartman

214-645-8294

pack.utsw@utsouthwestern.edu

CONTACT

Paola Lanza, MD

469-852-9550

paola.lanza@utsouthwestern.edu

CONTACT